COVID-19 as a catalyst for vaccine manufacturing: A South African experience

COVID-19 highlighted inequitable vaccine distribution and the urgent need for vaccine manufacturing capacity on the African continent. This resulted in a burst of scientific engagement and international funding to augment capacity on the continent. However, short-term investment needs to be reinforc...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Penny L., Gray, Glenda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265761/
https://www.ncbi.nlm.nih.gov/pubmed/37321166
http://dx.doi.org/10.1016/j.chom.2023.05.015
Descripción
Sumario:COVID-19 highlighted inequitable vaccine distribution and the urgent need for vaccine manufacturing capacity on the African continent. This resulted in a burst of scientific engagement and international funding to augment capacity on the continent. However, short-term investment needs to be reinforced by a robust, strategic long-term plan to ensure sustainability.

Ejemplares similares